Immutep Limited (ASX:IMM) Reports Q3 FY25 Milestones and Financial Position
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.
Radiopharm Theranostics (ASX:RAD) initiates Phase 2b U.S. trial of 18F-RAD101, advancing diagnostic capabilities for brain metastasis.
Sayona Mining (ASX:SYA) announces substantial high-grade lithium drill results, enhancing the resource potential of its Moblan Lithium Project.
Surefire Resources NL (ASX:SRN) extends Yidby gold mineralisation, advances copper systems, secures offtake agreement, and receives R&D rebate.
Future Battery Minerals (ASX:FBM) announces key gold targets at Kal North and expands Western Australia landholdings, enhancing exploration prospects.
Australian Rare Earths Limited (ASX:AR3) finalises farm-in agreement for EL6678, expanding its Overland Uranium Project with promising exploration results.
Hot Chili Limited (ASX:HCH) releases the Costa Fuego PFS and maiden ore reserve, highlighting robust financials and significant exploration advancements.
Cynata Therapeutics (ASX:CYP) reports progress in key clinical trials and maintains a strong financial position in Q1 2025.
Perpetual Resources (ASX:PEC) reports exceptional high-grade lithium and caesium assays at the Igrejinha Project, preparing for its maiden drill campaign in June.
Livium Ltd (ASX:LIT) signs a A$5M recycling agreement with Sell & Parker, boosting its revenue and growth prospects.